Rapid screening of EGFR mutations in patients with non-small cell lung cancer, breast cancer and head and neck cancer treated with gefitinib on a compassionate-use program

被引：0
|
作者：
Murray, S
Razis, E
Linardou, H
Lambropoulos, S
Briasoulis, E
Skarlos, D
Pectasides, D
Kalofonos, HP
Papadimitriou, C
Kosmidis, P
Fountzilas, G
机构：
[1] Metropolitan Hosp, Athens, Greece
[2] HYGEIA Med Ctr, Athens, Greece
[3] Ioannina Univ Hosp, Ioannina, Greece
[4] Attikon Univ Hosp, Athens, Greece
[5] Alexandra Univ Hosp, Patras, Greece
[6] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece
[7] Henry Dunan Med Ctr, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [1] Screening for EGFR mutations in patients with head and neck cancer treated with gefitinib on a compassionate-use program: A hellenic cooperative oncology group study
    Murray, Samuel
    Linardou, Helena
    Razis, Evangelia
    Pectasides, Dimitrios
    Fountzilas, George
    ANNALS OF ONCOLOGY, 2006, 17 : 180 - 180
  • [2] Screening for EGFRMutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study
    Murray, Samuel
    Bobos, Mattheos
    Angouridakis, Nikolaos
    Nikolaou, Angelos
    Linardou, Helena
    Razis, Evangelia
    Fountzilas, George
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [3] Compassionate-use gefitinib in non-small cell lung cancer: Survival and safety in 21,064 patients in an expanded access program
    Ochs, J
    Grous, JJ
    Krebs, A
    CHEST, 2004, 126 (04) : 731S - 731S
  • [4] Treatment of non-small-cell lung cancer with gefitinib (IRESSA) in a compassionate-use program: The Portuguese experience
    Araujo, A
    Teixeira, M
    Figueiredo, A
    Correia, J
    Melo, M
    Parente, B
    Bernardo, M
    Queiroga, H
    Barata, F
    LUNG CANCER, 2005, 49 : S234 - S234
  • [5] Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program
    Razis, E
    Skarlos, D
    Briasoulis, E
    Dimopoulos, M
    Fountzilas, G
    Lambropoulos, S
    Rigatos, S
    Kopterides, P
    Efstathiou, H
    Tzamakou, E
    Bakoyannis, C
    Pectasides, D
    Makatsoris, T
    Varthalitis, G
    Papadopoulos, S
    Kosmidis, R
    ANTI-CANCER DRUGS, 2005, 16 (02) : 191 - 198
  • [6] Serum EGFR in patients with non-small cell lung cancer (NSCLC) treated with gefitinib
    Spreafico, A
    Gregorc, V
    Ludovini, V
    Pistola, L
    Amoroso, M
    Tofanetti, F
    Compagnoni, A
    Aondio, G
    Tonato, M
    Villa, E
    LUNG CANCER, 2005, 49 : S112 - S113
  • [7] CLINICAL EXPERIENCE USE GEFITINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH A MUTATION EGFR
    Vozniy, Eduard
    Popov, Anatoly
    Galkin, Michail
    Astrakhankina, Tamara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1214 - S1214
  • [8] EGFR mutations and gefitinib sensitivity in patients with metastatic non-squamous non-small cell lung cancer
    Moiseyenko, V.
    Imyanitov, E.
    Levchenko, E.
    Procenko, S.
    Orlova, R.
    Iyevleva, A.
    Buslov, K.
    Ulibina, Y.
    Matsko, D.
    Moiseyenko, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] EGFR genomic gain in Japanese non-small cell lung cancer patients treated with gefitinib.
    Varella-Garcia, M.
    Mitsudomi, T.
    Yatabe, Y.
    Kosaka, T.
    Nakajima, E.
    Franklin, W.
    Bunn, P. A., Jr.
    Hirsch, F. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 405S - 405S
  • [10] DETECTING EGFR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Hammoudeh, Z. A.
    Antonova, O.
    Staneva, R.
    Nikolova, D.
    Kyuchukov, Y.
    Penev, A.
    Mintchev, T.
    Koleva, V
    Hadjidekova, S.
    Toncheva, D.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2018, 21 (01) : 13 - 17
12345